Tcrx T cell Therapy(Second Affiliated Hospital School Of Zhejiang University School Of Medicine)

N/A

Report date: 2022/07/11 15:31:49

Base Information

Drug NameTcrx T cell Therapy(Second Affiliated Hospital School Of Zhejiang University School Of Medicine)
Drug Alias NameTcrx T cell
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > TCR therapy
Mechanisms of ActionCluster of differentiation 8 modulatorsT lymphocyte replacements
TargetsCluster of differentiation 8
Therapy Area/IndicationsGastroesophageal Junction NeoplasmsStomach Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSecond Affiliated Hospital School Of Zhejiang University School Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesSecond Affiliated Hospital School Of Zhejiang University School Of Medicine
Inactive CompaniesN/A
Active IndicationsGastroesophageal Junction NeoplasmsStomach Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A